CN100579569C - Oral Chinese medicine composition for treating liver cirrhosis - Google Patents
Oral Chinese medicine composition for treating liver cirrhosis Download PDFInfo
- Publication number
- CN100579569C CN100579569C CN200710014234A CN200710014234A CN100579569C CN 100579569 C CN100579569 C CN 100579569C CN 200710014234 A CN200710014234 A CN 200710014234A CN 200710014234 A CN200710014234 A CN 200710014234A CN 100579569 C CN100579569 C CN 100579569C
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- liver
- medicine composition
- liver cirrhosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an oral Chinese medicine for effectively curing cirrhosis of liver with obvious therapeutic effect. Said Chinese medicine preparation is made up by using 12 Chinese medicinal materials of Chinese angelica root, salvia root, prepared turtle shell, peach kernel, notoginseng, red peony root and others through a certain preparation process.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition of orally for curing hepatocirrhosis.Belong to the field of Chinese medicines.
Background technology
Liver cirrhosis is a hepatitis interstitialis chronica, the formation of liver cirrhosis is because for a long time under harmful factors (as ethanol, hepatitis virus, Developmental and Metabolic Disorder) effect, hepatic necrosis, degeneration and inflammatory reaction, thereby stimulate the liver sternzellen, the Fibrotic material of a lot of formation of secretion, in the course of time, liver develops to liver cirrhosis from fibrosis.It is a kind of common chronic disease of clinical manifestation.Liver cirrhosis can be divided into compensatory cirrhosis and decompensated liver cirrhosis by course of disease development.
Liver cirrhosis is by causing that reason can be divided into: 1, the liver cirrhosis that causes of viral hepatitis, be liver cirrhosis after the viral hepatitis; 2, alcoholic cirrhosis; 3, parasitic liver cirrhosis; 4, biliary cirrhosis; 5, drug intoxication liver cirrhosis; 6, metabolic liver cirrhosis; 7, congestive cirrhosis (chronic heart failure); 8, nutritional cirrhosis; 9, congenital syphilis liver cirrhosis; 10, agnogenic liver cirrhosis.
On " Chinese Medical Association the tenth secondary whole nation viral hepatitis and hepatopathy academic conference " that hold in Beijing in May, 2005, talk about in well-known expert's specialist paper: the liver cirrhosis of present 20%-30% can develop into decompensated liver cirrhosis; 6%-15% can develop into hepatocellular carcinoma.And five-year survival rate: compensatory cirrhosis is 55%, and decompensated liver cirrhosis is 14%, and dying from hepatitis B dependency hepatopathy every year is 300,000-500,000 people.Therefore the treatment of liver cirrhosis is very urgent.Liver cirrhosis can be by therapy of combining Chinese and Western medicine and the positive partner treatment of patient; strengthen maintenance; delay and reduce liver function and lose compensatory, protection and recover liver function; adjust albumen ratio; blocking-up and reverse hepatic fibrosis, liver cirrhosis prevent the appearance of liver failure and hepatocarcinoma, improve life quality; prolong the patient and receive a mandate, reduce case fatality rate.Domestic and international state-of-the-art treatment means is at present: (1) combination of Chinese and Western medicine protects the liver, antiviral therapy; (2) liver value of moving; (3) splenectomy; (4) spleen is got involved; (5) artificial liver etc.More than several treatment meanss have operative therapy expense costliness, side effect is big, the deficiency of late result difference.
Summary of the invention
The present invention overcomes the deficiency of existing method, and a kind of Chinese medicine composition of orally for curing hepatocirrhosis is provided, and all selects natural Chinese medicinal herb for use, from effective treatment liver cirrhosis.
Technical scheme of the present invention is: the Chinese medicine composition of this kind orally for curing hepatocirrhosis, it is characterized in that, make raw materials of effective components and be: Radix Angelicae Sinensis 6～12, Radix Salviae Miltiorrhizae 10～20, Carapax Trionycis (processed) 25～30, Semen Persicae 8～15, Rhizoma Curcumae 6～9, Pheretima 5～10, Radix Curcumae 3～9, Herba Lycopi 6～12, Herba Cirsii 4.5～9, Radix Notoginseng 10～20, Radix Paeoniae Rubra 6～12 and Radix Glycyrrhizae 5～8 by following weight portion.
Preparation and instructions of taking: be decocted in water for oral dose, potion on the one, potion is taken at twice, and ten days is a course of treatment.
Further technical scheme of the present invention is: the Chinese medicine composition of this kind orally for curing hepatocirrhosis, it is characterized in that, make raw materials of effective components and be: Radix Angelicae Sinensis 10, Radix Salviae Miltiorrhizae 15, Carapax Trionycis (processed) 28, Semen Persicae 14, Rhizoma Curcumae 8, Pheretima 8, Radix Curcumae 6, Herba Lycopi 10, Herba Cirsii 8, Radix Notoginseng 15, Radix Paeoniae Rubra 8 and Radix Glycyrrhizae 6 by following weight portion.
Preparation and instructions of taking: be decocted in water for oral dose, potion on the one, potion is taken at twice, and ten days is a course of treatment.
Pharmacological action:
Radix Salviae Miltiorrhizae can reduce the content of TGF-β 1RNA, suppresses hepatic stellate cell (HSC) and is converted into fibroblastic karyokinesis and propagation, and obviously suppress the pathologic increase of I, II and IV Collagen Type VI amount.Semen Persicae extract can effectively suppress the anabolism of matrix components such as collagen by activity that improves the hepatic tissue collagenase and the activation that suppresses hepatic stellate cell, promotes its catabolism.Pheretima then may be by reducing α-smooth muscle actin (α-SMA, be the sign of hepatic stellate cell activator), TGF-β 1, TIMP-1 protein expression and promote matrix metalloproteinase-13 (MMP-13) protein expression and suppress the formation of rat liver fibrosis tissue, the Lumbricus collagenase that itself the contains interstitial collagenase of can directly degrading.Radix Angelicae Sinensis then can significantly be suppressed to fibroblast proliferation, and it is synthetic to suppress the interior collagen of liver, promotes liver cell regeneration.Carapax Trionycis (processed) can be supported bright heat clearing away, suppressing the hyperactive liver to relieve the wind syndrome, hard masses softening and resolving.Control the consumptive fever hectic fever due to YIN-deficiency, stirring of wind due to deficiency of YIN, malaria with general debility malaria with splenomegaly, lump in the abdomen mass beside the umbilicus, amenorrhea menometrorrhagia, pediatric epilepsy scared.。Simultaneously, Herba Lycopi, Herba Cirsii, Radix Paeoniae Rubra, Rhizoma Curcumae, Radix Curcumae etc. all can be by anti-liver injury, improve liver microcirculation, promote approach such as liver cell regeneration to participate in the different links of fibrosis.Radix Glycyrrhizae then with middle emergency, lung moistening, the detoxifcation, coordinating the actions of various ingredients in a prescription.Control weakness of the spleen and stomach, lack of appetite, the stomachache loose stool, the overstrain heating, the consumptive lung disease cough, cardiopalmus is fainted from fear; Give birth to usefulness, control laryngopharynx swelling and pain, peptic ulcer, ulcer sores is separated poison of drug and alimentary toxicosis
After the present invention mixed said medicine, its drug effect synergism in the liver cirrhosis therapeutic process, had been obtained unexpected remarkable result.The Chinese medicine composition of this kind orally for curing hepatocirrhosis is through clinical 50 example checkings, and effective percentage reaches more than 90%.
Model case:
Example one: the king so-and-so, man, 34 years old.Sensation stomachache is hard to bear suddenly before 3 years for the patient, goes examination in hospital to find the lobules of liver structure disturbance, and pseudolobuli forms.Be liver cirrhosis after diagnosing.Patient hepatocyte edema, the organizational structure disorder, and see proliferation of fibrous tissue, and the portal area lymphocytic infiltration, visible pseudolobuli forms.Give with the traditional Chinese medicine composition for treating of this kind orally for curing hepatocirrhosis after two months, the hepatocyte edema absorbs, inflammation is clearly better, fibrous tissue reduces, pseudolobuli disappears.After continuing to strengthen treatment five courses of treatment, recovery from illness.
Example two: Dong so-and-so, man, 29 years old.The patient found liver cirrhosis before 4 years, and the examination in hospital result shows that liver function is undesired: glutamate pyruvate transaminase 136u/L, and hepatic fibrosis index obviously increases, and B ultrasonic shows: liver cirrhosis, splenomegaly.Be diagnosed as: " hepatitis cirrhosis third type active stage ".Give treatments such as Chinese medicine composition with this kind orally for curing hepatocirrhosis protects the liver, antiviral, fibrosis.Liver power recovery is normal after one week, and hepatitis C virus does not duplicate after March, HCV-RNA 0cp/ml, and hepatic fibrosis index is normal, and B ultrasonic shows the spleen retraction after half a year, and stable disease reaches clinical cure substantially.
Example three: Zou so-and-so, woman, 30 years old.Found liver cirrhosis before 2 years, at examination in hospital, liver function AST/ALT:71/92u/l, Tbil/Dbil:88.6/46.3umol/L, A/G 29/45g/L, blood ammonia: 87.3umol/L, through multi-treatment, it is all ineffective to take a large amount of Chinese-western medicine preparations.The Chinese medicine composition of oral this kind orally for curing hepatocirrhosis, one the course of treatment state of an illness take a turn for the better gradually, continue to take and consolidate curative effect, liver function recovery is normal after three courses of treatment.
Example four: grandson so-and-so, woman, 56 years old.Suffering from liver cirrhosis nearly ten years is interrupted over 10 years and takes Chinese medicine, the symptom fashion time difference, a month tired sx of cause also hypomnesis occurs, obnubilation, and delirium is multi-lingual, look into through outpatient service: AST:96, ALT138, TDil83.4, DBil57.2, A/G:27/46, B ultrasonic: liver cirrhosis, ascites, air spots, portal vein 1.5cm, the real light 0.73cm of gallbladder is double-deck, the thick 4.7cm of spleen.Give the traditional Chinese medicine composition for treating with this kind orally for curing hepatocirrhosis, the check liver function is normal fully after four courses of treatment, and albumen is inverted and is obtained correcting, and ascites disappears, and portal vein attenuates, and it is normal that spleen and spleen V recover.
The specific embodiment
Example one: a kind of Chinese medicine composition of orally for curing hepatocirrhosis, make raw materials of effective components and be: Radix Angelicae Sinensis 6, Radix Salviae Miltiorrhizae 10, Carapax Trionycis (processed) 25, Semen Persicae 8, Rhizoma Curcumae 6, Pheretima 5, Radix Curcumae 3, Herba Lycopi 6, Herba Cirsii 4.5, Radix Notoginseng 10, Radix Paeoniae Rubra 6 and Radix Glycyrrhizae 5 by following weight portion.
Preparation and instructions of taking: be decocted in water for oral dose, potion on the one, potion is taken at twice, and ten days is a course of treatment.
Example two: a kind of Chinese medicine composition of orally for curing hepatocirrhosis, make raw materials of effective components and be: Radix Angelicae Sinensis 12, Radix Salviae Miltiorrhizae 20, Carapax Trionycis (processed) 30, Semen Persicae 15, Rhizoma Curcumae 9, Pheretima 10, Radix Curcumae 9, Herba Lycopi 12, Herba Cirsii 9, Radix Notoginseng 20, Radix Paeoniae Rubra 12 and Radix Glycyrrhizae 8 by following weight portion.
System and instructions of taking: with example one.
Example three: a kind of Chinese medicine composition of orally for curing hepatocirrhosis, make raw materials of effective components and be: Radix Angelicae Sinensis 2, Radix Salviae Miltiorrhizae 13, Carapax Trionycis (processed) 25, Semen Persicae 12, Rhizoma Curcumae 9, Pheretima 9, Radix Curcumae 8, Herba Lycopi 11, Herba Cirsii 7, Radix Notoginseng 17, Radix Paeoniae Rubra 10 and Radix Glycyrrhizae 7 by following weight portion.
System and instructions of taking: with example one.
Example four: a kind of Chinese medicine composition of orally for curing hepatocirrhosis, make raw materials of effective components and be: Radix Angelicae Sinensis 10, Radix Salviae Miltiorrhizae 15, Carapax Trionycis (processed) 28, Semen Persicae 14, Rhizoma Curcumae 8, Pheretima 8, Radix Curcumae 6, Herba Lycopi 10, Herba Cirsii 8, Radix Notoginseng 15, Radix Paeoniae Rubra 8 and Radix Glycyrrhizae 6 by following weight portion.
Preparation and instructions of taking: with example one.
Claims (2)
1, a kind of Chinese medicine composition of orally for curing hepatocirrhosis, it is characterized in that, making raw materials of effective components by following weight portion is: Radix Angelicae Sinensis 6～12, Radix Salviae Miltiorrhizae 10～20, Carapax Trionycis (processed) 25～30, Semen Persicae 8～15, Rhizoma Curcumae 6～9, Pheretima 5～10, Radix Curcumae 3～9, Herba Lycopi 6～12, Herba Cirsii 4.5～9, Radix Notoginseng 10～20, Radix Paeoniae Rubra 6～12 and Radix Glycyrrhizae 5～8 are decocted in water for oral dose.
2, the Chinese medicine composition of a kind of orally for curing hepatocirrhosis according to claim 1, it is characterized in that, make raw materials of effective components and be: Radix Angelicae Sinensis 10, Radix Salviae Miltiorrhizae 15, Carapax Trionycis (processed) 28, Semen Persicae 14, Rhizoma Curcumae 8, Pheretima 8, Radix Curcumae 6, Herba Lycopi 10, Herba Cirsii 8, Radix Notoginseng 15, Radix Paeoniae Rubra 8 and Radix Glycyrrhizae 6 by following weight portion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710014234A CN100579569C (en) | 2007-04-05 | 2007-04-05 | Oral Chinese medicine composition for treating liver cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710014234A CN100579569C (en) | 2007-04-05 | 2007-04-05 | Oral Chinese medicine composition for treating liver cirrhosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101024063A CN101024063A (en) | 2007-08-29 |
| CN100579569C true CN100579569C (en) | 2010-01-13 |
Family
ID=38742905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710014234A Expired - Fee Related CN100579569C (en) | 2007-04-05 | 2007-04-05 | Oral Chinese medicine composition for treating liver cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100579569C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105219698A (en) * | 2015-06-10 | 2016-01-06 | 赵振民 | People's glandulae salivariae minores epithelium ancestral cells is adopted to prepare hepatocellular method and application |
| CN113018407A (en) * | 2021-02-04 | 2021-06-25 | 陈海林 | A Chinese medicinal composition for treating liver cirrhosis and ascites due to liver cirrhosis, and its preparation method |
-
2007
- 2007-04-05 CN CN200710014234A patent/CN100579569C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101024063A (en) | 2007-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103356956A (en) | Traditional Chinese medicine composition for treating autoimmune liver disease and preparation method thereof | |
| CN101584758A (en) | A kind of pharmaceutical composition for the treatment of kidney deficiency | |
| CN100579569C (en) | Oral Chinese medicine composition for treating liver cirrhosis | |
| CN100409870C (en) | Chinese traditional medicinal composition for treating psoriasis | |
| CN104623196A (en) | Traditional Chinese medicinal composition used for treating chronic nephritis as well as preparation method and application thereof | |
| CN1490017A (en) | Medicines against rheunatoid and rheumatic diseases | |
| CN102008645B (en) | Traditional Chinese medicine capsule for treating jaundice hepatitis | |
| CN104548025A (en) | Traditional Chinese medicine pill for treating dysmenorrhea and preparation method of traditional Chinese medicine pill | |
| CN101129977A (en) | Orally taken traditional Chinese medicine decoction for treating cirrhosis | |
| CN1209123C (en) | Chinese medicine formula for hepatic disease | |
| CN1094057C (en) | Liver ascites treating medicine | |
| CN101032561B (en) | Chinese traditional medicine composition to be taken orally for curing hepatocirrhosis | |
| CN106344772A (en) | traditional Chinese medicine composition for treating rhinitis, external preparation and preparation method thereof | |
| CN1269513C (en) | Medicament for treating hepatic fibrosis and hepatic cirrhosis | |
| CN101757370A (en) | Medication for treating thyroiditis and preparation method thereof | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN104288579A (en) | Traditional Chinese medicine for treating chronic nephritis and preparation method thereof | |
| CN108704064A (en) | A kind of Chinese medicine composition and preparation method for treating AIDS | |
| CN101700347A (en) | Drug for curing strumitis and preparation method thereof | |
| CN1304034C (en) | Rheumatism treating plaster and its prepn | |
| CN104840806A (en) | Traditional Chinese medicine preparation having anti-rheumatoid effect, and production method thereof | |
| CN1279945C (en) | Chinese herbal medicine prepn for reversing liver cirrhosis | |
| CN104524487A (en) | Traditional Chinese medicine capsule for treating gastric tumour and preparation method thereof | |
| CN101130006A (en) | Traditional Chinese medicine for treating late hemorrhagic stroke | |
| CN1562333A (en) | Chinese traditional medicine for treating pulmonary heart disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100113 Termination date: 20100405 |